# Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers

> **NCT01240525** · PHASE2 · UNKNOWN · sponsor: **University College, London** · enrollment: 114 (actual)

## Conditions studied

- Graft Versus Host Disease
- Leukemia
- Lymphoma
- Myeloma
- Myelodysplastic Syndrome

## Interventions

- **OTHER:** CD4 DLI
- **OTHER:** No DLI

## Key facts

- **NCT ID:** NCT01240525
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-11
- **Primary completion:** 2019-11
- **Final completion:** 2019-11
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2019-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01240525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01240525, "Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01240525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*